• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DAVOL INC., SUB. C.R. BARD, INC. -1213643 SEPRAMESH IP; SURGICAL MESH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DAVOL INC., SUB. C.R. BARD, INC. -1213643 SEPRAMESH IP; SURGICAL MESH Back to Search Results
Catalog Number 5959124
Medical Device Problem Codes Defective Device (2588); Patient-Device Incompatibility (2682); Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes Adhesion(s) (1695); Erosion (1750); Fistula (1862); Unspecified Infection (1930); Pain (1994); Hernia (2240); Injury (2348); Disability (2371); Impaired Healing (2378)
Date of Event 09/09/2014
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
There is no connection that can be made at this time between the reported unspecified post-operative complications and any problem with the bard/davol sepramesh ip device used to treat the patient.The patient's attorney did not allege a specific device failure or patient adverse event, and no medical records have been provided.Based on the limited information provided at this time, no conclusions can be made.No lot number has been provided; therefore a review of the manufacturing records is not possible at this time.Should additional information be provided, a supplemental emdr will be submitted.Note: the information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event or Problem Description
The following was alleged by the patient's attorney: on (b)(6) 2010 - the patient underwent surgery with implant of an unspecified bard/davol sepramesh ip.On "ni/ni/ni" - the patient had unspecified injuries.As reported, the patient's attorney alleges a general claim "for past, present, and future damages, including but not limited to, mental and physical pain and suffering for severe and permanent personal injuries sustained".
 
Additional Manufacturer Narrative
There is no connection that can be made at this time between the reported unspecified post-operative complications and any problem with the bard/davol sepramesh ip device used to treat the patient.The patient's attorney did not allege a specific device failure or patient adverse event, and no medical records have been provided.Based on the limited information provided at this time, no conclusions can be made.No lot number has been provided; therefore a review of the manufacturing records is not possible at this time.Addendum: this supplemental emdr is submitted to document additional information provided.Root cause is inconclusive; no conclusion can be made as to the extent to which the implant may have caused or contributed to the patient's postoperative course.Note, the manufacturing date (15-mar-2010) is considered to be a best estimate.This supplemental emdr represents the sepramesh ip (device #1).An additional emdr was submitted to represent the soft mesh (device #2).Note: section a through f - the information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event or Problem Description
The following was alleged by the patient's attorney: (b)(6) 2010 - the patient underwent surgery with implant of an unspecified bard/davol sepramesh ip.Ni/ni/ni - the patient had unspecified injuries.As reported, the patient's attorney alleges a general claim "for past, present, and future damages, including but not limited to, mental and physical pain and suffering for severe and permanent personal injuries sustained".Addendum per additional information provided: (b)(6) 2010 ¿ patient was diagnosed with recurrent ventral hernia thereby underwent laparoscopic repair with the implant of sepramesh ip(device #1).Per op notes, ¿extensive adhesions around the previous synthetic mesh has been tacted as well as several hernia defects around the mesh were noted.A sepramesh ip (device #1) was placed over the mesh through peritoneal cavity and tacked circumferentially.¿ (b)(6) 2014 ¿ patient was diagnosed with nonhealing abdominal wound, infected abdominal mesh thereby underwent partial removal of mesh (device #1).Per op notes, ¿a large piece of bile stained synthetic mesh with some purulent fluid was removed.Abscess were drained.A sepramesh ip (device #1) was completely adherent to the bowel.Area of bowel had eroded through mesh causing enterocutaneous fistula.A piece of infected mesh was removed and rest of mesh kept in place." (b)(6) 2014 ¿ patient was diagnosed with chronic nonhealing anterior abdominal wall and enterocutaneous fistula abdominal wall thereby underwent open repair.Per op notes, ¿the skin graft was placed over the wound bed and suction was kept over the fistula to prevent succus spillage.¿ (b)(6) 2015 ¿ patient was diagnosed with infected abdominal mesh, enterocutaneous fistula and large incisional hernia thereby underwent open repair with the removal of mesh (device #1).Per op notes, ¿the patient had a large skin grafted abdomen from previous mesh (device #1) infection and enterocutaneous fistula were excised.Extensive lysis of adhesions was done.Two small bowel resections were performed to taken down both the enterocutaneous fistulas.A biological mesh (sttartice) was placed underlay to cover the defect using sutures.¿ (b)(6) 2016 ¿ patient was diagnosed with recurrent incisional hernia thereby underwent open repair with implant of bard soft mesh.Per op notes, ¿a superior portion of the hernia sac was fused to the biological mesh.Extensive lysis of adhesion were performed.Tar portion of the procedure was undertaken.The large bard soft mesh (device #2) was placed overlying the posterior sheath and transfixed to the anterior abdominal wall using sutures.¿ (b)(6) 2016 ¿ patient was diagnosed with chronic draining abdominal wound thereby underwent evacuation of abdominal seroma.(b)(6) 2016 ¿ patient had serous drainage and scar tissue was excised.(b)(6) 2017 ¿ patient was diagnosed with chronic nonhealing sinus tract thereby underwent open repair.Per op notes, ¿sinus tract was excised.The mesh appeared well incorporated into the abdominal wall without any evidence of any infection or contamination of the mesh.¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SEPRAMESH IP
Common Device Name
SURGICAL MESH
Manufacturer (Section D)
DAVOL INC., SUB. C.R. BARD, INC. -1213643
100 crossings blvd.
warwick RI 02886
Manufacturer (Section G)
BARD SHANNON LIMITED 3005636544
san geronimo industrial park
lot #1, road #3, km 79.7
humacao PR 00791
Manufacturer Contact
andrew topoulos
100 crossings blvd.
warwick, RI 02886
4018258495
MDR Report Key7386136
Report Number1213643-2018-00857
Device Sequence Number13743416
Product Code FTL
UDI-Device Identifier00801741031793
UDI-Public(01)00801741031793(17)120328(10)HUUC0448
Combination Product (Y/N)N
Initial Reporter StateRI
Initial Reporter CountryUS
PMA/510(K) Number
K063739
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2010
Device Explanted Year2015
Reporter Type Manufacturer
Report Source Other,Consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 07/02/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/28/2012
Device Catalogue Number5959124
Device Lot NumberHUUC0448
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/16/2018
Supplement Date Received by Manufacturer06/13/2025
Initial Report FDA Received Date03/30/2018
Supplement Report FDA Received Date07/02/2025
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured03/15/2010
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Disability; Required Intervention;
Patient Age51 YR
Patient SexFemale
-
-